Join us – with patients, industry leaders and a patient advocacy group to learn how to implement a magnetic resonance imaging (MRI) study designed to minimize patient burden. Participate and ask questions at the live AMRA webinar titled The Patient Experience Using MRI in DMD Clinical Trials – “Shed Light Through MRI” on Thursday, April 21, 2022 @ 11:00 am – 12:30 pm EDT
In this webinar patients, as well as PPMD, a patient advocacy group, and experts in Neuromuscular Disorders (NMD) clinical trials, and imaging from Pfizer, Inc and AMRA Medical, will discuss the value of incorporating magnetic resonance imaging (MRI) into clinical trials and strategies for incorporating whole muscle MRI assessments into Duchenne Muscular Dystrophy (DMD) clinical trials.
Successful incorporation of imaging into a clinical trial requires careful consideration of the patient population and the patient experience. Study sponsors, like Pfizer, should carefully consider how a study can be designed to minimize patient burden, while still collecting essential information about the disease status. In this webinar, the featured speakers will review the value of muscle MRI to understand potential therapies. The speakers will also discuss the patient experience with MRI, and why to consider incorporating MRI into DMD clinical trials.